Deborah A. Kuban
University of Texas MD Anderson Cancer Center
Quality of lifeCancerInternal medicineRadiologyUrologySurgeryOncologyStage (cooking)External beam radiotherapyProstateBrachytherapyAndrogen deprivation therapyDiseaseProstatectomyProstate cancerProstate-specific antigenGynecologyNuclear medicineExternal beam radiationRadiation therapyMedicine
343Publications
71H-index
16.1kCitations
Publications 342
Newest
#1Nikhil G. Thaker (University of Texas MD Anderson Cancer Center)H-Index: 13
#2Rajat J. Kudchadker (University of Texas MD Anderson Cancer Center)H-Index: 24
Last. Thomas W. Feeley (Harvard University)H-Index: 23
view all 11 authors...
INTRODUCTION Integrated quality improvement (QI) and cost reduction strategies can help increase value in cancer care. Time-driven activity-based costing (TDABC) is a bottom-up costing tool that measures resource use over the full care cycle. We applied standard QI and TDABC methods to improve workflow efficiency and reduce costs for MRI-guided prostate brachytherapy. METHODS AND MATERIALS We constructed process maps of the baseline prostate brachytherapy workflow from initial consultation throu...
Source
#1Brian DeH-Index: 1
#2Deborah A. KubanH-Index: 71
Last. Chad TangH-Index: 32
view all 3 authors...
Source
1 CitationsSource
Source
#1David Boyce-Fappiano (University of Texas MD Anderson Cancer Center)H-Index: 3
#2Tharakeswara K. Bathala (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Steven J. Frank (University of Texas MD Anderson Cancer Center)H-Index: 58
view all 17 authors...
Abstract Purpose MRI-assisted radiosurgery (MARS) is a modern technique for prostate brachytherapy that provides superior soft tissue contrast. The purpose of this analysis was to evaluate treatment planning factors associated with urinary toxicity, particularly damage to the membranous urethra (MUL) and external urethral sphincter (EUS), after MARS. Material and Methods We retrospectively reviewed 227 patients treated with MARS. Comparisons were made between several factors including preimplant...
Source
#1Ibrahim Abu-Gheida (University of Texas MD Anderson Cancer Center)H-Index: 2
#2Tharakeswara K. Bathala (University of Texas MD Anderson Cancer Center)H-Index: 9
Last. Chad Tang (University of Texas MD Anderson Cancer Center)H-Index: 32
view all 15 authors...
Purpose Patients with prostate cancer presenting with advanced T stage, mainly T4, might have a unique pattern of nodal failure and disease involvement that is not typically covered when local therapy is offered. We attempted to identify common sites of nodal disease presentation and failure for patients presenting with cT4 prostate cancer. Methods and Materials All patients with treatment-naive cT4 prostate cancer were retrospectively identified. All patients were required to have a confirmed d...
5 CitationsSource
#1P. Johnston (University of Texas MD Anderson Cancer Center)H-Index: 3
#2Janice L. Kitchens (University of Texas MD Anderson Cancer Center)
Last. Deborah A. Kuban (University of Texas MD Anderson Cancer Center)H-Index: 71
view all 8 authors...
To plan for a proactive approach to support patients traveling for their treatment during the COVID-19 pandemic, a network of oncology hospitals worked within existing collaborative agreements to define policies and procedures to transition care for patients living in communities in close proximity to a member institution. Nurse leaders were instrumental in collaborating with and leading interprofessional partners to achieve these outcomes. These efforts led to patients' abilities to continue tr...
1 CitationsSource
#1Chad Tang (University of Texas MD Anderson Cancer Center)H-Index: 32
#2Xiudong Lei (University of Texas MD Anderson Cancer Center)H-Index: 22
Last. Benjamin D. Smith (University of Texas MD Anderson Cancer Center)H-Index: 62
view all 13 authors...
Abstract Background Recent trends in payer and patient preferences increasingly incentivize time-efficient (≤2 weeks treatment time) prostate cancer treatments. Methods National Medicare claims from Jan 1, 2011 through Dec 31, 2014 were analyzed to identify newly diagnosed prostate cancers. Three ‘radical treatment' cohorts were identified (prostatectomy, brachytherapy, and stereotactic body radiation therapy [SBRT]) and matched to an active surveillance (AS) cohort by using inverse probability ...
3 CitationsSource
#1Chad Tang (University of Texas MD Anderson Cancer Center)H-Index: 32
#2Karen E. Hoffman (University of Texas MD Anderson Cancer Center)H-Index: 37
Last. Deborah A. Kuban (University of Texas MD Anderson Cancer Center)H-Index: 71
view all 3 authors...
Source
#1Justin R. Gregg (University of Texas MD Anderson Cancer Center)H-Index: 10
#1Justin R. Gregg (University of Texas MD Anderson Cancer Center)H-Index: 5
Last. Jeri Kim (MSD: Merck & Co.)H-Index: 19
view all 17 authors...
Abstract Objectives To report biopsy-related and oncologic outcomes in a large prospective active surveillance cohort that was initiated in the pre-MRI era and to additionally identify clinical factors associated with disease reclassification in order to inform future studies designed to improve enrollment and follow-up on AS. Methods Patients were prospectively enrolled at a single institution from 2006 to 2014 and followed until 2016. Men with Gleason 6 or 7 disease were eligible, and those wi...
2 CitationsSource